Finding solutions to a threat on worldwide public health.
In the history of the United Nations, the General Assembly has only held high-level meetings on health issues three times: HIV in 2001, non-communicable diseases in 2011 and Ebola in 2013. Today, all 193 member states are set to sign a declaration to tackle antimicrobial resistance (AMR).
With AMR at the top of the news agenda SfAM is proud to announce the details for our final event of the year, the Antimicrobial Resistance (AMR) meeting on 24 November 2016.
In this one-day conference, we aim to explore the latest in tackling AMR with regards to the key points of the 2014 Review on Antimicrobial Resistance. We’ll be looking at infection control, improved diagnostics and the development of new and novel compounds to address the evident “discovery void” when it comes to antimicrobials.
The threat of antibiotic resistance has been highlighted by scientists for decades, largely prompted by the industrial production of medicine. The discoverer of penicillin, Alexander Fleming, warned of the predicament we face today while accepting his Nobel Prize in 1945: “There is the danger that the ignorant man may easily underdose himself and by exposing his microbes to non-lethal quantities of the drug make them resistant”.
Current statistics from The Review on Antimicrobial Resistance suggest more than 700,000 people die each year due to drug-resistant infections, though the numbers could be much greater as there’s no international system to monitor these deaths.
The keynote speaker for our November meeting will be the UK’s chief medical officer, Professor Dame Sally Davies. Responding to the United Nations declaration, Davies said: “Drug-resistant infections are firmly on the global agenda, but now the real work begins.
“We need governments, the pharmaceutical industry, health professionals and the agricultural sector to follow through on their commitments to save modern medicine.”
Also speaking at the event will be Paul Hoskisson, Senior Lecturer in Microbiology at the University of Strathclyde. Commenting on the 2014 Review on AMR, Dr. Hoskisson said: “The resistance to antibiotics is inevitable, we always have to have drugs in the pipeline. Unfortunately the pipeline is no longer like a running tap, it’s a very slow drip.”
SfAM warmly invites you to attend an event that promises to provide colleagues from across the academic, policy, public and private sectors with the opportunity to network and discuss cutting-edge research on antimicrobial resistance.
Download the flyer
Categories: SfAM News